Drug discontinuation: Carbamazepine Capsule, Extended Release (CARBATROL)
FDA lists 3 presentations as To Be Discontinued. Companies: Takeda Pharmaceuticals USA Inc..
- Published by source
- 2025-12-19
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Takeda Pharmaceuticals USA Inc.
- Products
- Carbamazepine Capsule, Extended Release CARBATROL
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: To Be Discontinued
Remedy / actions:
- Discontinuation of the manufacture of the drug
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2025-12-19
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #1007 | new | 2026-10-22 | c00eb6b1d7fc…71e807 | 1f852a617841…9f585e |
Chain head: #1076 8ad5adc30b9b…88ce20